OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Health Politics Policy and Law is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
The Unequal Pandemic: COVID-19 and Health Inequalities	25
Scripting Death: Stories of Assisted Dying in America	24
Section 1115 Substance Use Disorder Waivers: Opportunities and Limitations	20
The Line between Medicaid and Marketplace: Coverage Effects from Wisconsin's Partial Expansion	16
MAHA Won't Make Americans Healthy Again: The Politicization of U.S. Federal Health Agencies During the Second Trump Administration	14
The Politics of the Gender Gap in COVID-19: Partisanship, Health Behavior, and Policy Preferences in the United States	14
Why Some Nonelderly Adult Medicaid Enrollees Appear Ineligible Based on Their Annual Income	13
Entrenching Inequity, Eroding Democracy: State Preemption of Local Housing Policy	13
EU Economic Governance as a Supranational Determinant of Health Inequalities in the Eurozone	13
The Limits to Food and Beverage Industry Influence over Fiscal and Regulatory Policy in Latin America	13
The Impacts of Politicization on Public Health Workers: The COVID-19 Pandemic in Oregon and Montana	13
Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits	12
Public Health Under Attack: Continuity, Discontinuity, and History	12
Assessing US Pharmaceutical Policy and Pricing Reform Legislation in Light of European Price and Cost Control Strategies	12
Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.	12
Ultimate Price: The Value We Place on Life	11
Authoritarian Regime Legitimacy and Health Care Provision: Survey Evidence from Contemporary China	11
Medicaid's Political Development since 1965: How a Fragmented and Unequal Program Has Expanded	10
The EU as a Political Determinant of Global Health: The Case of Research and Development Incentives for Orphan Medicines and Biotechnology	10
State Courts, State Legislatures, and Setting Abortion Policy	10
Medicare for All—Running Down a Dream	10
Implementing Primary Care Reform in France: Bargaining, Policy Adaptation, and the Maisons de Santé Pluriprofessionnelles	10
Hospital Consolidation Across Geographic Markets: Insights from Market Participants on Mechanisms for Price Increases	9
State Efforts to Regulate Provider Networks and Directories: Lessons for the Future	9
Market Failure, State Failure: The Political Economy of Supply Chain Strengthening to Ensure Equitable Access to Vaccines and Medicines in Low- and Middle-Income Countries	8

Does Policy Uncertainty Boost Vaccine Hesitancy? Political Controversy, the FDA, and COVID-19 Vaccine Hesitancy in Fall 2020	8
Variation in Public Support for Government Action on Unexpected Medical Bills	7
What the Evolution of 1332 Waivers Tells Us about Their Innovative Potential	7
Introduction: The Politics of Abortion 50 Years afterRoe	7
Grow and Hide: The History of America's Health Care State.	7
Building Power for Health: The Grassroots Politics of Sustaining and Strengthening Medicaid	7
International Reference Pricing in the Context of US Drug Policy	7
Vaccine Nationalism: How China's State Media Misinform about Western Vaccines and Highlight the Successes of Chinese Vaccines to Different Audiences	7
Criminal Records and Licensure in Five Allied Health Professions: Is There Evidence of a Disparate Impact on Historically Marginalized Groups?	7
Medicaid Waivers to Address Homelessness: Political Development and Policy Trajectories	6
The Political Economy of Market Power in Pharmaceuticals	6
It’s Only a Crisis if It’s Fit to Print: Examining the Relationship Between Overdose Rates, News Coverage, and the Presence of the Opioid Crisis in State Legislative Campaigns	5
Science and Public Health in the Trump Era: The Dismantling of Evidence and Institutions and Proposals for Reconstruction	5
The Political Determinants of Health and the European Union	5
Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices	5
Strategies to Promote Vaccine Uptake in the COVID-19 Pandemic: Exploring the “Ladder of Intrusiveness” in Three Countries	5
Is Redistribution Good for Our Health? Examining the Macrocorrelation between Welfare Generosity and Health across EU Nations over the Last 40 Years	5
Potemkin Protections: Assessing Provider Directory Accuracy and Timely Access for Four Specialties in California	5
Lots of Pain for Little Gain: Three Decades of Medicaid Estate Recovery	5
Intellectual Property and the Politics of Public Good during COVID-19: Framing Law, Institutions, and Ideas during TRIPS Waiver Negotiations at the WTO	4
Self-Sourced Medication Abortion, Physician Authority, and the Contradictions of Abortion Care	4
Administering a Chill Pill? Better Regulation and the Potential for Regulatory Chill in European Union Health Policy	4
Entrenched Opportunity: Medicaid, Health Systems, and Solutions to Homelessness	4
More Than Words? How Highlighting Target Populations Affects Public Opinion about the Medicaid Program	4
Medicare at 60: A Popular Program Facing Challenges	4
Incentivizing COVID-19 Vaccination in a Polarized and Partisan United States	4